406 related articles for article (PubMed ID: 20619491)
1. Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study.
Arias-Santiago S; Gutiérrez-Salmerón MT; Castellote-Caballero L; Buendía-Eisman A; Naranjo-Sintes R
J Am Acad Dermatol; 2010 Sep; 63(3):420-9. PubMed ID: 20619491
[TBL] [Abstract][Full Text] [Related]
2. Hypertension and aldosterone levels in women with early-onset androgenetic alopecia.
Arias-Santiago S; Gutiérrez-Salmerón MT; Buendía-Eisman A; Girón-Prieto MS; Naranjo-Sintes R
Br J Dermatol; 2010 Apr; 162(4):786-9. PubMed ID: 19906217
[TBL] [Abstract][Full Text] [Related]
3. Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA).
Baggio B; Budakovic A; Perissinotto E; Maggi S; Cantaro S; Enzi G; Grigoletto F;
Nephrol Dial Transplant; 2005 Jan; 20(1):114-23. PubMed ID: 15572387
[TBL] [Abstract][Full Text] [Related]
4. Androgenetic alopecia as an early marker of benign prostatic hyperplasia.
Arias-Santiago S; Arrabal-Polo MA; Buendía-Eisman A; Arrabal-Martín M; Gutiérrez-Salmerón MT; Girón-Prieto MS; Jimenez-Pacheco A; Calonje JE; Naranjo-Sintes R; Zuluaga-Gomez A; Serrano Ortega S
J Am Acad Dermatol; 2012 Mar; 66(3):401-8. PubMed ID: 21835498
[TBL] [Abstract][Full Text] [Related]
5. The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia.
Mumcuoglu C; Ekmekci TR; Ucak S
Eur J Dermatol; 2011; 21(1):79-82. PubMed ID: 21224180
[TBL] [Abstract][Full Text] [Related]
6. Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study.
Matilainen V; Laakso M; Hirsso P; Koskela P; Rajala U; Keinänen-Kiukaanniemi S
J Cardiovasc Risk; 2003 Jun; 10(3):227-31. PubMed ID: 12775957
[TBL] [Abstract][Full Text] [Related]
7. Association of early-onset androgenetic alopecia and metabolic syndrome in Thai men: a case-control study.
Pengsalae N; Tanglertsampan C; Phichawong T; Lee S
J Med Assoc Thai; 2013 Aug; 96(8):947-51. PubMed ID: 23991602
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.
Martínez MA; Puig JG; Mora M; Aragón R; O'Dogherty P; Antón JL; Sánchez-Villares T; Rubio JM; Rosado J; Torres R; Marcos J; Pallardo LF; Banegas JR;
Metabolism; 2008 Sep; 57(9):1232-40. PubMed ID: 18702949
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.
Hu G; Qiao Q; Tuomilehto J; Balkau B; Borch-Johnsen K; Pyorala K;
Arch Intern Med; 2004 May; 164(10):1066-76. PubMed ID: 15159263
[TBL] [Abstract][Full Text] [Related]
10. Elevated aldosterone levels in patients with androgenetic alopecia.
Arias-Santiago S; Gutiérrez-Salmerón MT; Castellote-Caballero L; Naranjo-Sintes R
Br J Dermatol; 2009 Nov; 161(5):1196-8. PubMed ID: 19519833
[TBL] [Abstract][Full Text] [Related]
11. Is androgenetic alopecia a risk for atherosclerosis?
Dogramaci AC; Balci DD; Balci A; Karazincir S; Savas N; Topaloglu C; Yalcin F
J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):673-7. PubMed ID: 19250324
[TBL] [Abstract][Full Text] [Related]
12. Androgenetic alopecia and insulin resistance in young men.
González-González JG; Mancillas-Adame LG; Fernández-Reyes M; Gómez-Flores M; Lavalle-González FJ; Ocampo-Candiani J; Villarreal-Pérez JZ
Clin Endocrinol (Oxf); 2009 Oct; 71(4):494-9. PubMed ID: 19094069
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome in childhood obesity.
Serap S; Mevlüt B; Inanç C; Ender S
Indian Pediatr; 2007 Sep; 44(9):657-62. PubMed ID: 17921554
[TBL] [Abstract][Full Text] [Related]
14. Sex hormone-binding globulin and risk of hyperglycemia in patients with androgenetic alopecia.
Arias-Santiago S; Gutiérrez-Salmerón MT; Buendía-Eisman A; Girón-Prieto MS; Naranjo-Sintes R
J Am Acad Dermatol; 2011 Jul; 65(1):48-53. PubMed ID: 21511365
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome in Saudi Arabia.
Al-Nozha M; Al-Khadra A; Arafah MR; Al-Maatouq MA; Khalil MZ; Khan NB; Al-Mazrou YY; Al-Marzouki K; Al-Harthi SS; Abdullah M; Al-Shahid MS; Al-Mobeireek A; Nouh MS
Saudi Med J; 2005 Dec; 26(12):1918-25. PubMed ID: 16380773
[TBL] [Abstract][Full Text] [Related]
16. Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey.
Su LH; Chen TH
Br J Dermatol; 2010 Aug; 163(2):371-7. PubMed ID: 20426781
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of dyslipidaemia in men and woman with androgenic alopecia.
Arias-Santiago S; Gutiérrez-Salmerón MT; Buendía-Eisman A; Girón-Prieto MS; Naranjo-Sintes R
Acta Derm Venereol; 2010 Sep; 90(5):485-7. PubMed ID: 20814623
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
[TBL] [Abstract][Full Text] [Related]
19. Gender-specific association of androgenetic alopecia with metabolic syndrome in a middle-aged Korean population.
Yi SM; Son SW; Lee KG; Kim SH; Lee SK; Cho ER; Kim IH; Shin C
Br J Dermatol; 2012 Aug; 167(2):306-13. PubMed ID: 22486172
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome in Japanese patients with obstructive sleep apnea syndrome.
Sasanabe R; Banno K; Otake K; Hasegawa R; Usui K; Morita M; Shiomi T
Hypertens Res; 2006 May; 29(5):315-22. PubMed ID: 16832151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
